Tumor Location at Trans-Urethral Resection Is Predictive of Ipsilateral Pelvic Lymph-Nodal Metastases in Patients Undergoing Radical Cystectomy for Bladder Cancer - Beyond the Abstract
The article, which is based on a retrospective analysis of 239 patients, identifies a key finding: lateral bladder wall tumors are associated with a higher percentage of ipsilateral positive lymph nodes. This reinforces the prognostic relevance of tumor location during TURB. Linear regression models demonstrating a statistically significant association between lateral tumor location and positive lymph nodes lend further credibility to the findings.
The study builds on existing knowledge that primary tumor characteristics influence lymphovascular spread in bladder cancer. It also supports previous research that suggests certain bladder locations, like the trigone, are more prone to lymphatic dissemination.
However, one area where the article could be expanded is in its discussion of clinical implications. While the results suggest lateral tumor location predicts ipsilateral metastasis, the study does not recommend specific changes to the standard PLND approach. Importantly, the study reports a 17% incidence of contralateral node positivity, a non-negligible “crossover” between sides.
Future studies, particularly those involving larger, multi-institutional cohorts, would be valuable to confirm these findings. Incorporating molecular or genetic markers could provide deeper insights into why lateral bladder tumors are more prone to lymphatic spread.
In summary, this study offers important preliminary data suggesting that tumor location during TURB is predictive of ipsilateral lymph-nodal metastasis in bladder cancer patients. While further research is needed to validate the findings and explore their broader clinical implications, the article substantially contributes to urologic oncology. It challenges the current one-size-fits-all approach to PLND in radical cystectomy and opens the door to more individualized, location-based surgical planning. For this reason, we consider the study to be hypothesis-generating, paving the way for future research on whether PLND can be limited or intensified based on tumor location.
Written by: Riccardo Giuseppe Bertolo, MD, PhD, Ricercatore Universitario UOC Urologia, Azienda Ospedaliera Universitaria Integrata (AOUI) Verona, Verona, Italia
Read the Abstract